EirGen Pharma Scaling for Commercialisation
EirGen Pharma are pleased to announce that they have a successful go-live in July 2010 with DocCompliance from QUMAS, one of the leading providers of Compliance Solutions to highly regulated companies, with ProcessCompliance to follow in early Q3 2010.
QUMAS DocCompliance and ProcessCompliance will provide EirGen Pharma with an integrated solution to improve document control and reduce approval lifecycles of regulatory documents. EirGen Pharma will also use the integrated solution to automate Change Control and Non-Conformance Management to drive efficiencies across both processes. EirGen Pharma will roll out the QUMAS solution to all employees.
"EirGen as a business is scaling rapidly and needs the infrastructure to support this growth. From a documentation control and compliance perspective, QUMAS provides the solution to this challenge," said Patsy Carney, Managing Director at EirGen Pharma. "QUMAS has provided us with a cost effective and flexible solution that addresses our compliance issues today, and can be expanded to meet our future needs."
"Our solution will provide EirGen with a single platform to manage all of their compliance programs," stated Kevin O`Leary, CEO of QUMAS. "This will enable EirGen to dramatically reduce their compliance costs and create a competitive advantage."
The go-live of QUMAS follows on from the successful implementation of SAP in June 2010 to manage operation planning and requisitions to support future growth of the organisation.
EirGen Pharma is a pharmaceutical company based in Waterford, Ireland. Using its purpose built high containment facility; the company specializes in the development, registration and manufacture of high potency solid dose products for global markets.